These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20113451)

  • 61. Donor vigilance data of a blood transfusion service: A multicenter analysis.
    Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
    Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of blood donor deferral causes in the Trinidad and Tobago National Blood Transfusion Service.
    Charles KS; Hughes P; Gadd R; Bodkyn CJ; Rodriguez M
    Transfus Med; 2010 Feb; 20(1):11-4. PubMed ID: 19788640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of changes to donor hemoglobin criteria on the rate of donor deferral.
    Perez GE; Gammon RR; Whitaker BI; Vassallo RR; Stubbs JR
    Transfusion; 2018 Nov; 58(11):2581-2588. PubMed ID: 30264396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Frequency and reasons of donor deferral prior to blood donation process: a single centre experience.
    Khurram S; Borhany M; Anwar N; Naseer I; Boota S; Mirza I; Nadeem M; Shamsi T
    Transfus Med; 2017 Feb; 27(1):10-15. PubMed ID: 27730692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Giving blood donors something to drink before donation can prevent fainting symptoms: is there a physiological or psychological reason?
    Vavic N; Pagliariccio A; Bulajic M; Dinić R; Marinozzi M
    Transfus Apher Sci; 2014 Aug; 51(1):65-9. PubMed ID: 25130724
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Source plasma deferral trends: A 3-year analysis of 255 centers in the United States.
    Schmidt AE; MacKercher J; Youngling B; Simon TL
    J Clin Apher; 2022 Feb; 37(1):31-39. PubMed ID: 34799876
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Syncopal-type reactions tend to be delayed and result in falls among elderly blood donors.
    Namba N; Ishimaru F; Kondo G; Hashizume T; Kunii N; Shibata R; Sawamura Y; Kato T
    Vox Sang; 2021 Jan; 116(1):36-41. PubMed ID: 32856735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vasovagal reaction rates and body weight: findings in high- and low-risk populations.
    Newman BH
    Transfusion; 2003 Aug; 43(8):1084-8. PubMed ID: 12869114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Caffeine attenuates vasovagal reactions in female first-time blood donors.
    Sauer LA; France CR
    Health Psychol; 1999 Jul; 18(4):403-9. PubMed ID: 10431942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
    Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
    Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trends in return behavior after an adverse event in Australian whole blood and plasma donors.
    Thijsen A; Masser B; Gemelli CN; Davison TE
    Transfusion; 2019 Oct; 59(10):3157-3163. PubMed ID: 31403178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Do deferred donors continue their donations? A large-scale register study on whole blood donor return in the Netherlands.
    Spekman MLC; van Tilburg TG; Merz EM
    Transfusion; 2019 Dec; 59(12):3657-3665. PubMed ID: 31621923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blood donor haemovigilance in Yaoundé, Cameroon.
    Nchinda EC; Tagny CT; Mbanya D
    Transfus Med; 2012 Aug; 22(4):257-61. PubMed ID: 22630141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Physiologic strategies to prevent fainting responses during or after whole blood donation.
    Wieling W; France CR; van Dijk N; Kamel H; Thijs RD; Tomasulo P
    Transfusion; 2011 Dec; 51(12):2727-38. PubMed ID: 21645008
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Factors associated with fainting: before, during and after whole blood donation.
    Bravo M; Kamel H; Custer B; Tomasulo P
    Vox Sang; 2011 Nov; 101(4):303-12. PubMed ID: 21535440
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions.
    France CR; Rader A; Carlson B
    Transfus Apher Sci; 2005 Oct; 33(2):99-106. PubMed ID: 16103014
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.
    Van Remoortel H; Moorkens D; Avau B; Compernolle V; Vandekerckhove P; De Buck E
    Vox Sang; 2019 May; 114(4):297-309. PubMed ID: 30972765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons.
    Al Shaer L; Sharma R; AbdulRahman M
    J Blood Med; 2017; 8():55-60. PubMed ID: 28579846
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Social support attenuates presyncopal reactions to blood donation.
    Hanson SA; France CR
    Transfusion; 2009 May; 49(5):843-50. PubMed ID: 19170990
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gender differences in presentation rates, deferrals and return behaviour among Norwegian blood donors.
    Misje AH; Bosnes V; Heier HE
    Vox Sang; 2010 Apr; 98(3 Pt 1):e241-8. PubMed ID: 19807904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.